School of Research
Ramanujan Hegde earned his MD and PhD from UCSF in 1999, completing his thesis work in the laboratory of Vishwanath Lingappa. He then started his own laboratory at the US National Institutes of Health, rising to the position of Senior Investigator.
More details to follow.
In an article in the journal Nature, Megan Scudellari reflects on the short history of PROTACs - a new type of drug design that is galvanising the Pharmaceutical industry, with the first PROTAC drug from Arvinas about to enter phase-1 clinical trials.